Ethinyl Estradiol and Drospirenone and Roflumilast
Determining the interaction of Ethinyl Estradiol and Drospirenone and Roflumilast and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Ethinyl estradiol may increase the blood levels and effects of roflumilast. You may be more likely to experience side effects of roflumilast such as diarrhea, nausea, abdominal pain, weight loss, headache, insomnia, depression, and anxiety. Let your doctor know if side effects become excessive or intolerable. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with oral contraceptives may increase the systemic exposure to roflumilast and its pharmacologically active N-oxide metabolite. In 20 healthy adult volunteers, administration of a single 500 mcg oral dose of roflumilast following repeated doses of a fixed combination oral contraceptive containing 0.075 mg gestodene and 0.03 mg ethinyl estradiol to steady state resulted in a 38% increase in roflumilast peak plasma concentration (Cmax) and a 51% increase in systemic exposure (AUC). The Cmax of roflumilast N-oxide was reduced by 12%, while AUC increased by 14%.
MANAGEMENT: Caution is advised when roflumilast is used in combination with oral contraceptives containing ethinyl estradiol and/or gestodene. Treatment with roflumilast should be re-evaluated if an interaction is suspected and persistent intolerability occurs. Patients should be advised to contact their doctor if they experience increased frequency and/or severity of side effects such as diarrhea, nausea, abdominal pain, weight loss, headache, insomnia, depression, and anxiety.
- "Product Information. Daliresp (roflumilast)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.
Generic Name: drospirenone / ethinyl estradiol
Brand name: Gianvi, Jasmiel, Loryna, Nikki, Ocella, Syeda, Vestura, Yasmin, Yaz, Zarah, Lo-Zumandimine, Zumandimine, Ocella, Yasmin 28, Yaz
Synonyms: Drospirenone and ethinyl estradiol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethinyl Estradiol and Drospirenone-Roflumilast Tablets
- Ethinyl Estradiol and Drospirenone-Rogaine
- Ethinyl Estradiol and Drospirenone-Rogaine (Minoxidil Topical Foam)
- Ethinyl Estradiol and Drospirenone-Rogaine (Minoxidil Topical Solution)
- Ethinyl Estradiol and Drospirenone-Rogaine Extra Strength Mens
- Ethinyl Estradiol and Drospirenone-Rogaine For Men Extra Strength Topical
- Roflumilast-Ethinyl estradiol and ethynodiol diacetate
- Roflumilast-Ethinyl Estradiol and Etonogestrel
- Roflumilast-Ethinyl estradiol and etonogestrel Vaginal
- Roflumilast-Ethinyl estradiol and etonogestrel vaginal ring
- Roflumilast-Ethinyl estradiol and levonorgestrel
- Roflumilast-Ethinyl estradiol and levonorgestrel extended-cycle